Multivariate analysis of chronic pain patients undergoing lidocaine infusions: Increasing pain severity and advancing age predict likelihood of clinically meaningful analgesia

Clinical Journal of Pain

Volumn 23, Issue 8, 2007, Pages 702-706

  Carroll, Ian ^a   Gaeta, Raymond ^a   Mackey, Sean ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Chronic pain; Cohort study; Intravenous lidocaine; Lidocaine; Lidocaine infusion; Logistic regression; Neuropathic pain; Palliative care; Prediction; Systemic lidocaine

Indexed keywords

ANTICONVULSIVE AGENT; DULOXETINE; LIDOCAINE; MEXILETINE; NONSTEROID ANTIINFLAMMATORY AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; AGING; ANALGESIA; ARTICLE; CHRONIC PAIN; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIZZINESS; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PREDICTION; PRIORITY JOURNAL; RATING SCALE; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGING; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; CHRONIC DISEASE; COHORT STUDIES; DATA COLLECTION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LIDOCAINE; LOGISTIC MODELS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34648834616     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31814b1afa     Document Type: Article

References (20)

1. Rowbotham MC. Mechanisms of neuropathic pain and their implications for the design of clinical trials. Neurology. 2005;65:S66-S73.
2. Gilron I, Bailey J, Weaver DF, et al. Patients' attitudes and prior treatments in neuropathic pain: a pilot study. Pain Res Manage. 2002;7:199-203.
3. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004;5:143-149.
4. Tanelian DL, Brose WG. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology. 1991;74:949-951.
5. Brose WG, Cousins MJ. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain. 1991;45:145-148.
6. Tremont-Lukats IW, Challapalli V, McNicol ED, et al. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg. 2005;101:1738-1749.
7. Attal N, Rouaud J, Brasseur L, et al. Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology. 2004;62:218-225.
8. Attal N, Gaude V, Brasseur L, et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology. 2000;54:564-574.
9. Galer BS, Harle J, Rowbotham MC. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. J Pain Symptom Manage. 1996;12:161-167.
10. Galer BS, Miller KV, Rowbotham MC. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology. 1993;43:1233-1235.
11. Schnider TW, Gaeta R, Brose W, et al. Derivation and cross-validation of pharmacokinetic parameters for computer-controlled infusion of lidocaine in pain therapy. Anesthesiology. 1996;84:1043-1050.
12. Farrar JT, Young JP Jr, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158.
13. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage. 2003;25:406-411.
14. Salaffi F, Stancati A, Silvestri CA, et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8:283-291.
15. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9-19.
16. Hosmer DW, Taber S, Lemeshow S. The importance of assessing the fit of logistic regression models: a case study. Am J Public Health. 1991;81:1630-1635.
17. Gottrup H, Bach FW, Juhl G, et al. Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain. Anesthesiology. 2006;104:527-536.
18. Rathmell JP, Ballantyne JC. Local anesthetics for the treatment of neuropathic pain: on the limits of meta-analysis. Anesth Analg. 2005;101:1736-1737.
19. Rowlingson JC, DiFazio CA, Foster J, et al. Lidocaine as an analgesic for experimental pain. Anesthesiology. 1980;52:20-22.
20. Sindrup SH, Jensen TS. Are sodium channel blockers useless in peripheral neuropathic pain? Pain. 2007;128:6-7.